Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Breast Oncology Unit, Gustave Roussy, Villejuif, France.
JCO Oncol Pract. 2023 Jun;19(6):353-361. doi: 10.1200/OP.23.00016.
Optimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at the end of primary treatment phase.
Pathway components included (1) a personalized survivorship care plan (SCP), (2) face-to-face survivorship education seminars and personalized consultation for supportive care referrals (Transition Day), (3) a mobile app delivering personalized education and self-management advice, and (4) decision aids for physicians focused on supportive care needs. A mixed-methods process evaluation was performed according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework including administrative data review, pathway experience survey (patient, physician, and organization), and focus group. The primary objective was patient-perceived satisfaction with the pathway (predefined progression criteria for pathway continuation ≥70%).
Over 6 months, 321 patients were eligible for the pathway and received a SCP and 98 (30%) attended the Transition Day. Among 126 patients surveyed, 77 (66.1%) responded. 70.1% received the SCP, 51.9% attended the Transition Day, and 59.7% accessed the mobile app. 96.1% of patients were very or completely satisfied with the overall pathway, whereas perceived usefulness was 64.8% for the SCP, 90% for the Transition Day, and 65.2% for the mobile app. Pathway implementation seemed to be positively experienced by physicians and the organization.
Patients were satisfied with a proactive survivorship care pathway, and the majority reported that its components were useful in supporting their needs. This study can inform the implementation of survivorship care pathways in other centers.
优化的综合生存护理服务提供不足。为了增强患者的自主权并最大限度地采用多学科支持性护理策略,以满足所有生存需求,我们在原发性治疗阶段结束时为早期乳腺癌患者实施了主动生存护理路径。
路径组成部分包括(1)个性化生存护理计划(SCP),(2)面对面生存教育研讨会和个性化支持性护理转诊咨询(过渡日),(3)提供个性化教育和自我管理建议的移动应用程序,以及(4)针对支持性护理需求的医生决策辅助工具。根据实施、采用、实施和维持框架(RE-AIM),采用混合方法进行过程评估,包括行政数据审查、路径体验调查(患者、医生和组织)和焦点小组。主要目标是患者对路径的满意度(路径继续的预定义进展标准≥70%)。
在 6 个月内,有 321 名患者符合路径条件,收到了 SCP,其中 98 名(30%)参加了过渡日。在接受调查的 126 名患者中,有 77 名(66.1%)做出了回应。70.1%的患者收到了 SCP,51.9%的患者参加了过渡日,59.7%的患者使用了移动应用程序。96.1%的患者对整个路径非常满意或完全满意,而对 SCP 的感知有用性为 64.8%,对过渡日的感知有用性为 90%,对移动应用程序的感知有用性为 65.2%。医生和组织似乎对路径的实施持积极态度。
患者对主动生存护理路径感到满意,大多数患者报告称,其组成部分在满足他们的需求方面非常有用。本研究可为其他中心实施生存护理路径提供信息。